{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:42:19Z","timestamp":1790959339554,"version":"4.1.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>Drug delivery into the brain has for long been a huge challenge as the blood\u2013brain barrier (BBB) offers great resistance to entry of foreign substances (with drugs inclusive) into the brain. This barrier in healthy individuals is protective to the brain, disallowing noxious substances present in the blood to get to the brain while allowing for the exchange of small molecules into the brain by diffusion. However, BBB is disrupted under certain disease conditions, such as cerebrovascular diseases including acute ischemic stroke and intracerebral hemorrhage, and neurodegenerative disorders including multiple sclerosis (MS), Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), and cancers. This review aims to provide a broad overview of present-day strategies for brain drug delivery, emphasizing novel delivery systems. Hopefully, this review would inspire scientists and researchers in the field of drug delivery across BBB to uncover new techniques and strategies to optimize drug delivery to the brain. Considering the anatomy, physiology, and pathophysiological functioning of the BBB in health and disease conditions, this review is focused on the controversies drawn from conclusions of recently published studies on issues such as the penetrability of nanoparticles into the brain, and whether active targeted drug delivery into the brain could be achieved with the use of nanoparticles. We also extended the review to cover novel non-nanoparticle strategies such as using viral and peptide vectors and other non-invasive techniques to enhance brain uptake of drugs.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1208\/s12249-021-02144-1","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:02:54Z","timestamp":1638565374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Multi-disciplinary Approach for Drug and Gene Delivery Systems to the Brain"],"prefix":"10.1208","volume":"23","author":[{"given":"Nkafu Bechem","family":"Ndemazie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana","family":"Inkoom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis Fualefeh","family":"Morfaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Aghimien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexter","family":"Ebesoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Agyare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"2144_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","volume":"19","author":"VL Feigin","year":"2020","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, Deuschl G, Parmar P, Brainin M, Murray C. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19:255\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(19)30411-9.","journal-title":"Lancet Neurol"},{"key":"2144_CR2","unstructured":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. (2019)."},{"key":"2144_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11030-016-9715-6","volume":"21","author":"K Lingineni","year":"2017","unstructured":"Lingineni K, Belekar V, Tangadpalliwar SR, Garg P. The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood-brain barrier (BBB) permeability. Mol Divers. 2017;21:355\u201365. https:\/\/doi.org\/10.1007\/s11030-016-9715-6.","journal-title":"Mol Divers"},{"key":"2144_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/acscombsci.6b00116","volume":"19","author":"D Goyal","year":"2017","unstructured":"Goyal D, Shuaib S, Mann S, Goyal B. Rationally designed peptides and peptidomimetics as inhibitors of amyloid-beta (Abeta) Aggregation: potential therapeutics of Alzheimer\u2019s disease. ACS Comb Sci. 2017;19:55\u201380. https:\/\/doi.org\/10.1021\/acscombsci.6b00116.","journal-title":"ACS Comb Sci"},{"key":"2144_CR5","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/s41598-018-19522-8","volume":"8","author":"M Ribecco-Lutkiewicz","year":"2018","unstructured":"Ribecco-Lutkiewicz M, Sodja C, Haukenfrers J, Haqqani AS, Ly D, Zachar P, Baumann E, Ball M, Huang J, Rukhlova M, Martina M, Liu Q, Stanimirovic D, Jezierski A, Bani-Yaghoub M. A novel human induced pluripotent stem cell blood-brain barrier model: applicability to study antibody-triggered receptor-mediated transcytosis. Sci Rep. 2018;8:1873. https:\/\/doi.org\/10.1038\/s41598-018-19522-8.","journal-title":"Sci Rep"},{"key":"2144_CR6","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s11095-017-2267-3","volume":"34","author":"SE Storck","year":"2017","unstructured":"Storck SE, Pietrzik CU. Endothelial LRP1 \u2013 a potential target for the treatment of Alzheimer\u2019s disease. Pharm Res. 2017;34:2637\u201351. https:\/\/doi.org\/10.1007\/s11095-017-2267-3.","journal-title":"Pharm Res"},{"key":"2144_CR7","doi-asserted-by":"publisher","unstructured":"Montaser A, J\u00e4rvinen J, Loeffler S, Huttunen J, Auriola S, Lehtonen M, Jalkanen A, Huttunen K. L-type amino acid transporter 1 enables the efficient brain delivery of small-sized prodrug across the blood\u2013brain barrier and into human and mouse brain parenchymal cells. ACS Chem Neurosci. 2020;11. https:\/\/doi.org\/10.1021\/acschemneuro.0c00564.","DOI":"10.1021\/acschemneuro.0c00564"},{"key":"2144_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biomaterials.2018.05.041","volume":"176","author":"X Zhang","year":"2018","unstructured":"Zhang X, He T, Chai Z, Samulski RJ, Li C. Blood-brain barrier shuttle peptides enhance AAV transduction in the brain after systemic administration. Biomaterials. 2018;176:71\u201383.","journal-title":"Biomaterials"},{"key":"2144_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-018-0100-y","volume":"15","author":"JB Alimonti","year":"2018","unstructured":"Alimonti JB, Ribecco-Lutkiewicz M, Sodja C, Jezierski A, Stanimirovic DB, Liu Q, Haqqani AS, Conlan W, Bani-Yaghoub M. Zika virus crosses an in vitro human blood brain barrier model. Fluids Barriers CNS. 2018;15:1\u20139.","journal-title":"Fluids Barriers CNS"},{"key":"2144_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd.2015.21","volume":"15","author":"WA Banks","year":"2016","unstructured":"Banks WA. From blood\u2013brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discovery. 2016;15:275\u201392. https:\/\/doi.org\/10.1038\/nrd.2015.21.","journal-title":"Nat Rev Drug Discovery"},{"key":"2144_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","volume":"31","author":"MM Patel","year":"2017","unstructured":"Patel MM, Patel BM. Crossing the blood\u2013brain barrier: recent advances in drug delivery to the brain. CNS Drugs. 2017;31:109\u201333.","journal-title":"CNS Drugs"},{"key":"2144_CR12","doi-asserted-by":"publisher","first-page":"e1138017","DOI":"10.1080\/21688370.2015.1138017","volume":"4","author":"C Greene","year":"2016","unstructured":"Greene C, Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 2016;4:e1138017\u2013e1138017. https:\/\/doi.org\/10.1080\/21688370.2015.1138017.","journal-title":"Tissue Barriers"},{"key":"2144_CR13","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1155\/2018\/6847971","volume":"1\u201315","author":"M Gharbavi","year":"2018","unstructured":"Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharmacol Sci. 2018;1\u201315:2018. https:\/\/doi.org\/10.1155\/2018\/6847971.","journal-title":"Adv Pharmacol Sci"},{"key":"2144_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev. 2019;99:21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017.","journal-title":"Physiol Rev"},{"key":"2144_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.lfs.2017.06.001","volume":"182","author":"P Hassanzadeh","year":"2017","unstructured":"Hassanzadeh P, Atyabi F, Dinarvand R. Application of modelling and nanotechnology-based approaches: the emergence of breakthroughs in theranostics of central nervous system disorders. Life Sci. 2017;182:93\u2013103. https:\/\/doi.org\/10.1016\/j.lfs.2017.06.001.","journal-title":"Life Sci"},{"key":"2144_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jconrel.2015.09.059","volume":"218","author":"X Wei","year":"2015","unstructured":"Wei X, Gao J, Zhan C, Xie C, Chai Z, Ran D, Ying M, Zheng P, Lu W. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. J Control Release. 2015;218:13\u201321. https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.059.","journal-title":"J Control Release"},{"key":"2144_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","volume":"31","author":"MM Patel","year":"2017","unstructured":"Patel MM, Patel BM. Crossing the blood-brain barrier: recent advances in drug delivery to the brain. CNS Drugs. 2017;31:109\u201333. https:\/\/doi.org\/10.1007\/s40263-016-0405-9.","journal-title":"CNS Drugs"},{"key":"2144_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/acschemneuro.5b00098","volume":"6","author":"CW Lindsley","year":"2015","unstructured":"Lindsley CW. 2014 global prescription medication statistics: strong growth and CNS well represented. ACS Chem Neurosci. 2015;6:505\u20136. https:\/\/doi.org\/10.1021\/acschemneuro.5b00098.","journal-title":"ACS Chem Neurosci"},{"issue":"Suppl 4","key":"2144_CR19","doi-asserted-by":"publisher","first-page":"S411","DOI":"10.1098\/rsif.2010.0158.focus","volume":"7","author":"Z Yang","year":"2010","unstructured":"Yang Z, Liu ZW, Allaker RP, Reip P, Oxford J, Ahmad Z, Ren G. A review of nanoparticle functionality and toxicity on the central nervous system. J R Soc Interface. 2010;7(Suppl 4):S411-422. https:\/\/doi.org\/10.1098\/rsif.2010.0158.focus.","journal-title":"J R Soc Interface"},{"key":"2144_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2:3\u201314. https:\/\/doi.org\/10.1602\/neurorx.2.1.3.","journal-title":"NeuroRx"},{"key":"2144_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","volume":"19","author":"O van Tellingen","year":"2015","unstructured":"van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat. 2015;19:1\u201312. https:\/\/doi.org\/10.1016\/j.drup.2015.02.002.","journal-title":"Drug Resist Updat"},{"key":"2144_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41\u201353. https:\/\/doi.org\/10.1038\/nrn1824.","journal-title":"Nat Rev Neurosci"},{"key":"2144_CR23","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1126\/science.1206936","volume":"334","author":"JI Alvarez","year":"2011","unstructured":"Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonni\u00e8re L, Bernard M, van Horssen J, de Vries HE, Charron F, Prat A. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science. 2011;334:1727\u201331. https:\/\/doi.org\/10.1126\/science.1206936.","journal-title":"Science"},{"key":"2144_CR24","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19:1584\u201396. https:\/\/doi.org\/10.1038\/nm.3407.","journal-title":"Nat Med"},{"key":"2144_CR25","doi-asserted-by":"publisher","unstructured":"Warren KE. Beyond the Blood:brain barrier: the importance of central nervous system (CNS) pharmacokinetics for the treatment of cns tumors, including diffuse intrinsic pontine glioma. Front Oncol. 2018;8. https:\/\/doi.org\/10.3389\/fonc.2018.00239.","DOI":"10.3389\/fonc.2018.00239"},{"key":"2144_CR26","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1073\/pnas.0712147105","volume":"105","author":"JH Grubb","year":"2008","unstructured":"Grubb JH, Vogler C, Levy B, Galvin N, Tan Y, Sly WS. Chemically modified \u03b2-glucuronidase crosses blood\u2013brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII. PNAS. 2008;105:2616\u201321. https:\/\/doi.org\/10.1073\/pnas.0712147105.","journal-title":"PNAS"},{"key":"2144_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1517\/17425247.3.3.419","volume":"3","author":"Y Su","year":"2006","unstructured":"Su Y, Sinko PJ. Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it? Expert Opin Drug Deliv. 2006;3:419\u201335. https:\/\/doi.org\/10.1517\/17425247.3.3.419.","journal-title":"Expert Opin Drug Deliv"},{"key":"2144_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s1537-1891(02)00201-x","volume":"38","author":"M Demeule","year":"2002","unstructured":"Demeule M, R\u00e9gina A, Jodoin J, Laplante A, Dagenais C, Berthelet F, Moghrabi A, B\u00e9liveau R. Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier. Vascul Pharmacol. 2002;38:339\u201348. https:\/\/doi.org\/10.1016\/s1537-1891(02)00201-x.","journal-title":"Vascul Pharmacol"},{"key":"2144_CR29","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32:1959\u201372. https:\/\/doi.org\/10.1038\/jcbfm.2012.126.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2144_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.addr.2019.02.007","volume":"148","author":"C Vissers","year":"2019","unstructured":"Vissers C, Ming G-L, Song H. Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders. Adv Drug Deliv Rev. 2019;148:239\u201351. https:\/\/doi.org\/10.1016\/j.addr.2019.02.007.","journal-title":"Adv Drug Deliv Rev"},{"key":"2144_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.carbpol.2017.10.030","volume":"180","author":"PK Singh","year":"2018","unstructured":"Singh PK, Srivastava AK, Dev A, Kaundal B, Choudhury SR, Karmakar S. 1, 3\u03b2-Glucan anchored, paclitaxel loaded chitosan nanocarrier endows enhanced hemocompatibility with efficient anti-glioblastoma stem cells therapy. Carbohyd Polym. 2018;180:365\u201375. https:\/\/doi.org\/10.1016\/j.carbpol.2017.10.030.","journal-title":"Carbohyd Polym"},{"key":"2144_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","volume":"392","author":"S Lapointe","year":"2018","unstructured":"Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet. 2018;392:432\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(18)30990-5.","journal-title":"Lancet"},{"key":"2144_CR33","doi-asserted-by":"publisher","first-page":"13529","DOI":"10.1038\/s41598-017-13234-1","volume":"7","author":"S Luo","year":"2017","unstructured":"Luo S, Cao Q, Ma K, Wang Z, Liu G, Lu C, Liu Y. Quantitative assessment of the blood-brain barrier opening caused by Streptococcus agalactiae hyaluronidase in a BALB\/c mouse model. Sci Rep. 2017;7:13529. https:\/\/doi.org\/10.1038\/s41598-017-13234-1.","journal-title":"Sci Rep"},{"key":"2144_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1021\/acschemneuro.8b00484","volume":"10","author":"A Anwar","year":"2019","unstructured":"Anwar A, Rajendran K, Siddiqui R, Raza Shah M, Khan NA. Clinically approved drugs against CNS diseases as potential therapeutic agents to target brain-eating amoebae. ACS Chem Neurosci. 2019;10:658\u201366. https:\/\/doi.org\/10.1021\/acschemneuro.8b00484.","journal-title":"ACS Chem Neurosci"},{"key":"2144_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jconrel.2005.07.024","volume":"108","author":"C Roney","year":"2005","unstructured":"Roney C, Kulkarni P, Arora V, Antich P, Bonte F, Wu A, Mallikarjuana N, Manohar S, Liang H-F, Kulkarni AR. Targeted nanoparticles for drug delivery through the blood\u2013brain barrier for Alzheimer\u2019s disease. J Control Release. 2005;108:193\u2013214.","journal-title":"J Control Release"},{"key":"2144_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fphar.2019.00202","volume":"10","author":"Z Jiang","year":"2019","unstructured":"Jiang Z, Gao W, Huang L. Tanshinones, Critical pharmacological components in Salvia miltiorrhiza. Front Pharmacol. 2019;10:202. https:\/\/doi.org\/10.3389\/fphar.2019.00202.","journal-title":"Front Pharmacol"},{"key":"2144_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101665","volume":"181","author":"KB Johnsen","year":"2019","unstructured":"Johnsen KB, Burkhart A, Thomsen LB, Andresen TL, Moos T. Targeting the transferrin receptor for brain drug delivery. Prog Neurobiol. 2019;181: 101665. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101665.","journal-title":"Prog Neurobiol"},{"key":"2144_CR38","doi-asserted-by":"publisher","unstructured":"Pulgar, V. M. Transcytosis to cross the blood brain barrier, new advancements and challenges. Front Neurosci. 2019;12. https:\/\/doi.org\/10.3389\/fnins.2018.01019.","DOI":"10.3389\/fnins.2018.01019"},{"key":"2144_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jconrel.2019.01.005","volume":"295","author":"KB Johnsen","year":"2019","unstructured":"Johnsen KB, Bak M, Melander F, Thomsen MS, Burkhart A, Kempen PJ, Andresen TL, Moos T. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo. J Control Release. 2019;295:237\u201349. https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.005.","journal-title":"J Control Release"},{"key":"2144_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-11220-1","volume":"7","author":"KB Johnsen","year":"2017","unstructured":"Johnsen KB, Burkhart A, Melander F, Kempen PJ, Vejlebo JB, Siupka P, Nielsen MS, Andresen TL, Moos T. Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma. Sci Rep. 2017;7:1\u201313. https:\/\/doi.org\/10.1038\/s41598-017-11220-1.","journal-title":"Sci Rep"},{"key":"2144_CR41","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1096\/fj.201600827R","volume":"31","author":"Y Molino","year":"2017","unstructured":"Molino Y, David M, Varini K, Jab\u00e8s F, Gaudin N, Fortoul A, Bakloul K, Masse M, Bernard A, Drobecq L, L\u00e9corch\u00e9 P, Temsamani J, Jacquot G, Khrestchatisky M. Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier. Faseb J. 2017;31:1807\u201327. https:\/\/doi.org\/10.1096\/fj.201600827R.","journal-title":"Faseb J"},{"key":"2144_CR42","doi-asserted-by":"publisher","unstructured":"Andr\u00e9 S, Larbanoix L, Verteneuil S, Stanicki D, Nonclercq D, Vander Elst L, Laurent S, Muller RN, Burtea C. Development of an LDL receptor-targeted peptide susceptible to facilitate the brain access of diagnostic or therapeutic agents. Biology (Basel). 2020;9:161. https:\/\/doi.org\/10.3390\/biology9070161.","DOI":"10.3390\/biology9070161"},{"key":"2144_CR43","doi-asserted-by":"publisher","unstructured":"Stebbins MJ, Lippmann ES, Faubion MG, Daneman R, Palecek SP, Shusta EV. Activation of RAR\u03b1, RAR\u03b3, or RXR\u03b1 increases barrier tightness in human induced pluripotent stem cell-derived brain endothelial cells. Biotechnol J.2018; 13. https:\/\/doi.org\/10.1002\/biot.201700093.","DOI":"10.1002\/biot.201700093"},{"key":"2144_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12987-020-00197-1","volume":"17","author":"M Yamashita","year":"2020","unstructured":"Yamashita M, Aoki H, Hashita T, Iwao T, Matsunaga T. Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells. Fluids Barriers CNS. 2020;17:36. https:\/\/doi.org\/10.1186\/s12987-020-00197-1.","journal-title":"Fluids Barriers CNS"},{"key":"2144_CR45","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s12264-019-00384-7","volume":"35","author":"Y Li","year":"2019","unstructured":"Li Y, Sun X, Liu H, Huang L, Meng G, Ding Y, Su W, Lu J, Gong S, Terstappen GC, Zhang R, Zhang W. Development of human in vitro brain-blood barrier model from induced pluripotent stem cell-derived endothelial cells to predict the in vivo permeability of drugs. Neurosci Bull. 2019;35:996\u20131010. https:\/\/doi.org\/10.1007\/s12264-019-00384-7.","journal-title":"Neurosci Bull"},{"key":"2144_CR46","doi-asserted-by":"publisher","first-page":"27162","DOI":"10.1039\/C7RA03208K","volume":"7","author":"W Shi","year":"2017","unstructured":"Shi W, Cui X, Shi J, Chen J, Wang Y. Overcoming the blood\u2013brain barrier for glioma-targeted therapy based on an interleukin-6 receptor-mediated micelle system. RSC Adv. 2017;7:27162\u20139. https:\/\/doi.org\/10.1039\/C7RA03208K.","journal-title":"RSC Adv"},{"key":"2144_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/bjc.2017.327","volume":"118","author":"JR Infante","year":"2018","unstructured":"Infante JR, Korn RL, Rosen LS, LoRusso P, Dychter SS, Zhu J, Maneval DC, Jiang P, Shepard HM, Frost G, Von Hoff DD, Borad MJ, Ramanathan RK. Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours. Br J Cancer. 2018;118:153\u201361. https:\/\/doi.org\/10.1038\/bjc.2017.327.","journal-title":"Br J Cancer"},{"key":"2144_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120565","volume":"601","author":"J Tampio","year":"2021","unstructured":"Tampio J, Loeffler S, Guillon M, Hugele A, Huttunen J, Huttunen K. Improved L-type amino acid transporter 1 (LAT1)-mediated delivery of anti-inflammatory drugs into astrocytes and microglia with reduced prostaglandin production. Int J Pharm. 2021;601: 120565. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120565.","journal-title":"Int J Pharm"},{"key":"2144_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ics.2005.02.012","volume":"1277","author":"Q Smith","year":"2005","unstructured":"Smith Q. Carrier-mediated transport to enhance drug delivery to brain. Int Congr Ser. 2005;1277:63\u201374. https:\/\/doi.org\/10.1016\/j.ics.2005.02.012.","journal-title":"Int Congr Ser"},{"key":"2144_CR50","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/pharmaceutics11100540","volume":"11","author":"S-S Hong","year":"2019","unstructured":"Hong S-S, Oh KT, Choi H-G, Lim S-J. Liposomal formulations for nose-to-brain delivery: recent advances and future perspectives. Pharmaceutics. 2019;11:540. https:\/\/doi.org\/10.3390\/pharmaceutics11100540.","journal-title":"Pharmaceutics"},{"key":"2144_CR51","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/cbdd.13128","volume":"91","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Zhang L, Peng Y, Yue Q, Hai L, Guo L, Wang Q, Wu Y. GLUT1 -mediated venlafaxine-thiamine disulfide system-glucose conjugates with \u201clock-in\u201d function for central nervous system delivery. Chem Biol Drug Des. 2018;91:707\u201316. https:\/\/doi.org\/10.1111\/cbdd.13128.","journal-title":"Chem Biol Drug Des"},{"key":"2144_CR52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/10717544.2018.1431978","volume":"25","author":"Q Yue","year":"2018","unstructured":"Yue Q, Peng Y, Zhao Y, Lu R, Fu Q, Chen Y, Yang Y, Hai L, Guo L, Wu Y. Dual-targeting for brain-specific drug delivery: synthesis and biological evaluation. Drug Delivery. 2018;25:426\u201334. https:\/\/doi.org\/10.1080\/10717544.2018.1431978.","journal-title":"Drug Delivery"},{"key":"2144_CR53","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/mt.2010.111","volume":"18","author":"DA Ryan","year":"2010","unstructured":"Ryan DA, Mastrangelo MA, Narrow WC, Sullivan MA, Federoff HJ, Bowers WJ. Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer\u2019s disease mice. Mol Ther. 2010;18:1471\u201381. https:\/\/doi.org\/10.1038\/mt.2010.111.","journal-title":"Mol Ther"},{"key":"2144_CR54","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/mt.2010.111","volume":"18","author":"DA Ryan","year":"2010","unstructured":"Ryan DA, Mastrangelo MA, Narrow WC, Sullivan MA, Federoff HJ, Bowers WJ. A\u03b2-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer\u2019s disease mice. Mol Ther. 2010;18:1471\u201381. https:\/\/doi.org\/10.1038\/mt.2010.111.","journal-title":"Mol Ther"},{"key":"2144_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.64","volume":"2","author":"A Alonso","year":"2013","unstructured":"Alonso A, Reinz E, Leuchs B, Kleinschmidt J, Fatar M, Geers B, Lentacker I, Hennerici MG, de Smedt SC, Meairs S. Focal Delivery of AAV2\/1-transgenes into the rat brain by localized ultrasound-induced BBB opening. Mol Ther Nucleic Acids. 2013;2: e73. https:\/\/doi.org\/10.1038\/mtna.2012.64.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2144_CR56","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jconrel.2018.07.043","volume":"286","author":"B Dos Santos Rodrigues","year":"2018","unstructured":"Dos Santos Rodrigues B, Oue H, Banerjee A, Kanekiyo T, Singh J. Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection. J Control Release. 2018;286:264\u201378. https:\/\/doi.org\/10.1016\/j.jconrel.2018.07.043.","journal-title":"J Control Release"},{"key":"2144_CR57","doi-asserted-by":"crossref","unstructured":"Albright BH, Storey CM, Murlidharan G, Rivera RMC, Berry GE Madigan VJ, Asokan A. Mapping the structural determinants required for AAVrh. 10 transport across the blood-brain barrier. Mol Ther. 2018;26:510\u2013523.","DOI":"10.1016\/j.ymthe.2017.10.017"},{"key":"2144_CR58","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13861","volume":"140","author":"SF Merkel","year":"2017","unstructured":"Merkel SF, Andrews AM, Lutton EM, Mu D, Hudry E, Hyman BT, Maguire CA, Ramirez SH. Trafficking of adeno-associated virus vectors across a model of the blood\u2013brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells. J Neurochem. 2017;140:216\u201330.","journal-title":"J Neurochem"},{"key":"2144_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12554-2","volume":"10","author":"L-P Wu","year":"2019","unstructured":"Wu L-P, Ahmadvand D, Su J, Hall A, Tan X, Farhangrazi ZS, Moghimi SM. Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide. Nat Commun. 2019;10:1\u201316. https:\/\/doi.org\/10.1038\/s41467-019-12554-2.","journal-title":"Nat Commun"},{"key":"2144_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neures.2017.02.007","volume":"120","author":"S Tanabe","year":"2017","unstructured":"Tanabe S, Inoue K-I, Tsuge H, Uezono S, Nagaya K, Fujiwara M, Kato S, Kobayashi K, Takada M. The use of an optimized chimeric envelope glycoprotein enhances the efficiency of retrograde gene transfer of a pseudotyped lentiviral vector in the primate brain. Neurosci Res. 2017;120:45\u201352. https:\/\/doi.org\/10.1016\/j.neures.2017.02.007.","journal-title":"Neurosci Res"},{"key":"2144_CR61","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4155\/tde.10.50","volume":"1","author":"SJ Gray","year":"2010","unstructured":"Gray SJ, Woodard KT, Samulski RJ. Viral vectors and delivery strategies for CNS gene therapy. Ther Deliv. 2010;1:517\u201334.","journal-title":"Ther Deliv"},{"key":"2144_CR62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/neuonc\/noy202","volume":"21","author":"MW Kieran","year":"2019","unstructured":"Kieran MW, Goumnerova L, Manley P, Chi SN, Marcus KJ, Manzanera AG, Polanco MLS, Guzik BW, Aguilar-Cordova E, Diaz-Montero CM, DiPatri AJ, Tomita T, Lulla R, Greenspan L, Aguilar LK, Goldman S. Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma. Neuro Oncol. 2019;21:537\u201346. https:\/\/doi.org\/10.1093\/neuonc\/noy202.","journal-title":"Neuro Oncol"},{"key":"2144_CR63","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1523\/JNEUROSCI.4785-13.2014","volume":"34","author":"A B\u00f6ckenhoff","year":"2014","unstructured":"B\u00f6ckenhoff A, Cramer S, W\u00f6lte P, Knieling S, Wohlenberg C, Gieselmann V, Galla H-J, Matzner U. Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A. J Neurosci. 2014;34:3122\u20139. https:\/\/doi.org\/10.1523\/JNEUROSCI.4785-13.2014.","journal-title":"J Neurosci"},{"key":"2144_CR64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4155\/tde.10.44","volume":"1","author":"P Vlieghe","year":"2010","unstructured":"Vlieghe P, Khrestchatisky M. Peptide-based vectors for blood\u2013brain barrier targeting and delivery of drugs to the central nervous system. Ther Deliv. 2010;1:489\u201394. https:\/\/doi.org\/10.4155\/tde.10.44.","journal-title":"Ther Deliv"},{"key":"2144_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2017.02.016","volume":"253","author":"T Schuster","year":"2017","unstructured":"Schuster T, M\u00fchlstein A, Yaghootfam C, Maksimenko O, Shipulo E, Gelperina S, Kreuter J, Gieselmann V, Matzner U. Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A. J Control Release. 2017;253:1\u201310. https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.016.","journal-title":"J Control Release"},{"key":"2144_CR66","unstructured":"Risk-Benefit Analysis of the use of Viral Vectors in Gene Therapy. 27."},{"key":"2144_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnins.2015.00021","volume":"9","author":"N Strazielle","year":"2015","unstructured":"Strazielle N, Ghersi-Egea J-F. Efflux transporters in blood-brain interfaces of the developing brain. Front Neurosci. 2015;9:21\u201321. https:\/\/doi.org\/10.3389\/fnins.2015.00021.","journal-title":"Front Neurosci"},{"key":"2144_CR68","first-page":"487","volume":"122","author":"MM Frank","year":"1993","unstructured":"Frank MM. The reticuloendothelial system and bloodstream clearance. J Lab Clin Med. 1993;122:487\u20138.","journal-title":"J Lab Clin Med"},{"key":"2144_CR69","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1073\/pnas.93.24.14164","volume":"93","author":"J Huwyler","year":"1996","unstructured":"Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A. 1996;93:14164\u20139. https:\/\/doi.org\/10.1073\/pnas.93.24.14164.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2144_CR70","doi-asserted-by":"publisher","unstructured":"Lakkadwala S, dos Santos Rodrigues B, Sun C, Singh J. Biodistribution of TAT or QLPVM coupled to receptor targeted liposomes for delivery of anticancer therapeutics to brain in vitro and in vivo. Nanomedicine. 2020;23:102112. https:\/\/doi.org\/10.1016\/j.nano.2019.102112.","DOI":"10.1016\/j.nano.2019.102112"},{"key":"2144_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2019.104828","volume":"225","author":"CRL de Azambuja Borges","year":"2019","unstructured":"de Azambuja Borges CRL, Silva NO, Rodrigues MR, Germani Marinho MA, de Oliveira FS, Cassiana M, Horn AP, Parize AL, Flores DC, Clementin RM, de Lima VR. Dimiristoylphosphatidylcholine\/genistein molecular interactions: A physico-chemical approach to anti-glioma drug delivery systems. Chem Phys Lipid. 2019;225:104828. https:\/\/doi.org\/10.1016\/j.chemphyslip.2019.104828.","journal-title":"Chem Phys Lipid"},{"key":"2144_CR72","doi-asserted-by":"publisher","unstructured":"Qu F, Wang P, Zhang K, Shi Y, Li Y, Li C, Lu J, Liu Q, Wang X. Manipulation of Mitophagy by \u201cAll-in-One\u201d nanosensitizer augments sonodynamic glioma therapy. Autophagy. 2019;1\u201323. https:\/\/doi.org\/10.1080\/15548627.2019.1687210","DOI":"10.1080\/15548627.2019.1687210"},{"key":"2144_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45137-8","volume":"9","author":"G Iachetta","year":"2019","unstructured":"Iachetta G, Falanga A, Molino Y, Masse M, Jab\u00e8s F, Mechioukhi Y, Laforgia V, Khrestchatisky M, Galdiero S, Valiante S. gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery. Sci Rep. 2019;9:1\u201313. https:\/\/doi.org\/10.1038\/s41598-019-45137-8.","journal-title":"Sci Rep"},{"key":"2144_CR74","doi-asserted-by":"publisher","first-page":"150","DOI":"10.34172\/apb.2020.021","volume":"10","author":"I Chauhan","year":"2020","unstructured":"Chauhan I, Yasir M, Verma M, Singh AP. Nanostructured lipid carriers: a groundbreaking approach for transdermal drug delivery. Adv Pharm Bull. 2020;10:150\u201365. https:\/\/doi.org\/10.34172\/apb.2020.021.","journal-title":"Adv Pharm Bull"},{"key":"2144_CR75","doi-asserted-by":"publisher","unstructured":"Mohammad N, Amir A, Mohammad Reza Saghatchi Z, Mehrdad H. Indinavir-loaded nanostructured lipid carriers to brain drug delivery: optimization, characterization and neuropharmacokinetic evaluation. Curr Drug Deliv. 2019;16:341\u2013354. https:\/\/doi.org\/10.2174\/1567201816666190123124429.","DOI":"10.2174\/1567201816666190123124429"},{"key":"2144_CR76","doi-asserted-by":"publisher","unstructured":"Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Patel RJ, Ajazuddin N, Ravichandiran V, Murty US, Alexander A. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. J Control Release. 2020;321:372\u2013415. https:\/\/doi.org\/10.1016\/j.jconrel.2020.02.020.","DOI":"10.1016\/j.jconrel.2020.02.020"},{"key":"2144_CR77","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/03639045.2019.1569039","volume":"45","author":"Z Karami","year":"2019","unstructured":"Karami Z, Zanjani MRS, Rezaee S, Rostamizadeh K, Hamidi M. Neuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancement. Drug Dev Ind Pharm. 2019;45:736\u201344. https:\/\/doi.org\/10.1080\/03639045.2019.1569039.","journal-title":"Drug Dev Ind Pharm"},{"key":"2144_CR78","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1080\/10837450.2019.1621897","volume":"24","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zhang B, Kebebe D, Guo L, Guo H, Li N, Pi J, Qi D, Guo P, Liu Z. Preparation, optimization and cellular uptake study of tanshinone I nanoemulsion modified with lactoferrin for brain drug delivery. Pharm Dev Technol. 2019;24:982\u201391. https:\/\/doi.org\/10.1080\/10837450.2019.1621897.","journal-title":"Pharm Dev Technol"},{"key":"2144_CR79","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3109\/10717544.2014.885999","volume":"22","author":"K Jain","year":"2015","unstructured":"Jain K, Sood S, Gowthamarajan K. Optimization of artemether-loaded NLC for intranasal delivery using central composite design. Drug Delivery. 2015;22:940\u201354. https:\/\/doi.org\/10.3109\/10717544.2014.885999.","journal-title":"Drug Delivery"},{"key":"2144_CR80","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","volume":"45","author":"DG Gadhave","year":"2019","unstructured":"Gadhave DG, Kokare CR. Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies. Drug Dev Ind Pharm. 2019;45:839\u201351. https:\/\/doi.org\/10.1080\/03639045.2019.1576724.","journal-title":"Drug Dev Ind Pharm"},{"key":"2144_CR81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1208\/s12249-019-1296-0","volume":"20","author":"P Kumar","year":"2019","unstructured":"Kumar P, Sharma G, Gupta V, Kaur R, Thakur K, Malik R, Kumar A, Kaushal N, Katare OP, Raza K. Oral delivery of methylthioadenosine to the brain employing solid lipid nanoparticles: pharmacokinetic, behavioral, and histopathological evidences. AAPS PharmSciTech. 2019;20:74. https:\/\/doi.org\/10.1208\/s12249-019-1296-0.","journal-title":"AAPS PharmSciTech"},{"key":"2144_CR82","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2174\/1389200221666200508074348","volume":"21","author":"S Raman","year":"2020","unstructured":"Raman S, Mahmood S, Hilles AR, Javed MN, Azmana M, Al-Japairai KAS. Polymeric Nanoparticles for brain drug delivery - a review. Curr Drug Metab. 2020;21:649\u201360. https:\/\/doi.org\/10.2174\/1389200221666200508074348.","journal-title":"Curr Drug Metab"},{"key":"2144_CR83","doi-asserted-by":"crossref","unstructured":"Rana V, Sharma R in: Applications of Targeted Nano Drugs and Delivery Systems Micro and Nano Technologies (eds Shyam S. Mohapatra et al.) 93\u2013131 (Elsevier, 2019).","DOI":"10.1016\/B978-0-12-814029-1.00005-3"},{"key":"2144_CR84","doi-asserted-by":"publisher","unstructured":"Zielinska A, Carreiro F, Oliveira AM, Neves A, Pires B, Venkatesh DN, Durazzo A, Lucarini M, Eder P, Silva AM, Santini A, Souto EB Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules. 2020;25. https:\/\/doi.org\/10.3390\/molecules25163731","DOI":"10.3390\/molecules25163731"},{"key":"2144_CR85","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11481-016-9685-6","volume":"12","author":"MJ Gomes","year":"2017","unstructured":"Gomes MJ, Fernandes C, Martins S, Borges F, Sarmento B. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier \u2013 from Targeting to Safe Administration. J Neuroimmune Pharmacol. 2017;12:107\u201319. https:\/\/doi.org\/10.1007\/s11481-016-9685-6.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2144_CR86","unstructured":"Mansoor KR. Advancement of polymer\u2013based nanoparticles as smart drug delivery systems in neurodegenerative medicine. 4."},{"key":"2144_CR87","doi-asserted-by":"crossref","unstructured":"Murahari M, Sundar L, Chaki S, Poongavanam V, Bhat P, Nayak UY. Conference on Drug Design and Discovery Technologies. (Royal Society of Chemistry, 2019).","DOI":"10.1039\/9781839160783"},{"key":"2144_CR88","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejpb.2019.10.004","volume":"145","author":"E Luque-Michel","year":"2019","unstructured":"Luque-Michel E, Sebastian V, Larrea A, Marquina C, Blanco-Prieto MJ. Co-encapsulation of superparamagnetic nanoparticles and doxorubicin in PLGA nanocarriers: Development, characterization and in vitro antitumor efficacy in glioma cells. Eur J Pharm Biopharm. 2019;145:65\u201375. https:\/\/doi.org\/10.1016\/j.ejpb.2019.10.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"2144_CR89","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s13346-017-0368-5","volume":"7","author":"J Gu","year":"2017","unstructured":"Gu J, Al-Bayati K, Ho EA. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes. Drug Deliv Transl Res. 2017;7:497\u2013506. https:\/\/doi.org\/10.1007\/s13346-017-0368-5.","journal-title":"Drug Deliv Transl Res"},{"key":"2144_CR90","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jecm.2014.10.015","volume":"6","author":"G Ajnai","year":"2014","unstructured":"Ajnai G, Chiu A, Kan T, Cheng C-C, Tsai T-H, Chang J. Trends of gold nanoparticle-based drug delivery system in cancer therapy. Journal of Experimental & Clinical Medicine. 2014;6:172\u20138. https:\/\/doi.org\/10.1016\/j.jecm.2014.10.015.","journal-title":"Journal of Experimental & Clinical Medicine"},{"key":"2144_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-44569-6","volume":"9","author":"M Khongkow","year":"2019","unstructured":"Khongkow M, Yata T, Boonrungsiman S, Ruktanonchai UR, Graham D, Namdee K. Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood\u2013brain barrier penetration. Sci Rep. 2019;9:1\u20139. https:\/\/doi.org\/10.1038\/s41598-019-44569-6.","journal-title":"Sci Rep"},{"key":"2144_CR92","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jphotochem.2018.08.041","volume":"367","author":"BC Swain","year":"2018","unstructured":"Swain BC, Mishra PP, Mishra H, Tripathy U. Monitoring the binding of serotonin to silver nanoparticles: a fluorescence spectroscopic investigation. J Photochem Photobiol, A. 2018;367:219\u201325. https:\/\/doi.org\/10.1016\/j.jphotochem.2018.08.041.","journal-title":"J Photochem Photobiol, A"},{"key":"2144_CR93","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.18632\/oncotarget.13503","volume":"8","author":"P Liang","year":"2016","unstructured":"Liang P, Shi H, Zhu W, Gui Q, Xu Y, Meng J, Guo X, Gong Z, Chen H. Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells. Oncotarget. 2016;8:7533\u20139. https:\/\/doi.org\/10.18632\/oncotarget.13503.","journal-title":"Oncotarget"},{"key":"2144_CR94","doi-asserted-by":"publisher","first-page":"20410","DOI":"10.1021\/acsami.7b03504","volume":"9","author":"Y Song","year":"2017","unstructured":"Song Y, Du D, Li L, Xu J, Dutta P, Lin Y. In vitro study of receptor-mediated silica nanoparticles delivery across blood\u2013brain barrier. ACS Appl Mater Interfaces. 2017;9:20410\u20136. https:\/\/doi.org\/10.1021\/acsami.7b03504.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2144_CR95","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.arabjc.2018.03.019","volume":"11","author":"BI Tamba","year":"2018","unstructured":"Tamba BI, Streinu V, Foltea G, Neagu AN, Dodi G, Zlei M, Tijani A, Stefanescu C. Tailored surface silica nanoparticles for blood-brain barrier penetration: Preparation and in vivo investigation. Arab J Chem. 2018;11:981\u201390. https:\/\/doi.org\/10.1016\/j.arabjc.2018.03.019.","journal-title":"Arab J Chem"},{"key":"2144_CR96","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jphotobiol.2018.11.008","volume":"190","author":"X Huo","year":"2019","unstructured":"Huo X, Zhang Y, Jin X, Li Y, Zhang L. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer\u2019s disease. J Photochem Photobiol, B. 2019;190:98\u2013102. https:\/\/doi.org\/10.1016\/j.jphotobiol.2018.11.008.","journal-title":"J Photochem Photobiol, B"},{"key":"2144_CR97","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/jcp.27019","volume":"234","author":"L Gholami","year":"2019","unstructured":"Gholami L, Tafaghodi M, Abbasi B, Daroudi M, Kazemi Oskuee R. Preparation of superparamagnetic iron oxide\/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool. J Cell Physiol. 2019;234:1547\u201359. https:\/\/doi.org\/10.1002\/jcp.27019.","journal-title":"J Cell Physiol"},{"key":"2144_CR98","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jare.2019.01.004","volume":"18","author":"R Mohammadinejad","year":"2019","unstructured":"Mohammadinejad R, Dadashzadeh A, Moghassemi S, Ashrafizadeh M, Dehshahri A, Pardakhty A, Sassan H, Sohrevardi S-M, Mandegary A. Shedding light on gene therapy: carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - A review. J Adv Res. 2019;18:81\u201393. https:\/\/doi.org\/10.1016\/j.jare.2019.01.004.","journal-title":"J Adv Res"},{"key":"2144_CR99","unstructured":"Froum SJ, Tarnow DP, Wallace SS, Jalbout Z, Cho SC, Rohrer MD, Prasad HS. The use of a mineralized allograft for sinus augmentation: an interim histological case report from a prospective clinical study. Compend Contin Educ Dent. 2005;26:259\u2013260, 262\u2013254, 266\u2013258; quiz 270\u2013251."},{"key":"2144_CR100","doi-asserted-by":"publisher","unstructured":"Hersh DS, Wadajkar SA, Roberts BN, Perez, JG, Connolly NP, Frenkel V, Winkles JA, Woodworth GF, Kim AJ. Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier. Curr Pharm Des. 2016;22:1177\u20131193. https:\/\/doi.org\/10.2174\/1381612822666151221150733","DOI":"10.2174\/1381612822666151221150733"},{"key":"2144_CR101","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijpharm.2018.10.029","volume":"553","author":"J Rohrer","year":"2018","unstructured":"Rohrer J, Lupo N, Bernkop-Schn\u00fcrch A. Advanced formulations for intranasal delivery of biologics. Int J Pharm. 2018;553:8\u201320.","journal-title":"Int J Pharm"},{"key":"2144_CR102","doi-asserted-by":"crossref","unstructured":"Bhattamisra SK, Shak AT, Xi LW, Safian NH, Choudhury H, Lim WM, Shahzad N, Alhakamy NA, Anwer MK, Radhakrishnan AK. Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease. Int J Pharm. 2020;579:119148.","DOI":"10.1016\/j.ijpharm.2020.119148"},{"key":"2144_CR103","doi-asserted-by":"crossref","unstructured":"Wang F, Yang Z, Liu M, Tao Y, Li Z, Wu Z, Gui S. Facile nose-to-brain delivery of rotigotine-loaded polymer micelles thermosensitive hydrogels: in vitro characterization and in vivo behavior study. Int J Pharm. 2020;577:119046.","DOI":"10.1016\/j.ijpharm.2020.119046"},{"key":"2144_CR104","doi-asserted-by":"crossref","unstructured":"Ahmad E, Lv Y, Zhu Q, Qi J, Dong X, Zhao W, Chen Z, Wu W, Lu Y. TAT modification facilitates nose-to-brain transport of intact mPEG-PDLLA micelles: Evidence from aggregation-caused quenching probes. Appl Mater Today. 2020;19:100556.","DOI":"10.1016\/j.apmt.2020.100556"},{"key":"2144_CR105","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2019.11.019","volume":"317","author":"C Chu","year":"2020","unstructured":"Chu C, Jablonska A, Lesniak WG, Thomas AM, Lan X, Linville RM, Li S, Searson PC, Liu G, Pearl M, Pomper MG, Janowski M, Magnus T, Walczak P. Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex. J Control Release. 2020;317:312\u201321. https:\/\/doi.org\/10.1016\/j.jconrel.2019.11.019.","journal-title":"J Control Release"},{"key":"2144_CR106","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2967\/jnumed.118.218792","volume":"60","author":"WG Lesniak","year":"2019","unstructured":"Lesniak WG, Chu C, Jablonska A, Du Y, Pomper MG, Walczak P, Janowski M. A distinct advantage to intraarterial delivery of (89)Zr-Bevacizumab in PET imaging of mice with and without osmotic opening of the blood-brain barrier. J Nucl Med. 2019;60:617\u201322. https:\/\/doi.org\/10.2967\/jnumed.118.218792.","journal-title":"J Nucl Med"},{"key":"2144_CR107","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/ALN.0b013e318182c81b","volume":"109","author":"S Joshi","year":"2008","unstructured":"The Potential and the Pitfalls, Joshi S, Meyers PM, Ornstein E. Intracarotid Delivery of Drugs. Anesthesiology. 2008;109:543\u201364. https:\/\/doi.org\/10.1097\/ALN.0b013e318182c81b.","journal-title":"Anesthesiology"},{"key":"2144_CR108","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3171\/jns.2000.92.4.0599","volume":"92","author":"T Siegal","year":"2000","unstructured":"Siegal T, Rubinstein R, Bokstein F, Schwartz A, Lossos A, Shalom E, Chisin R, Gomori J. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans. J Neurosurg. 2000;92:599\u2013605. https:\/\/doi.org\/10.3171\/jns.2000.92.4.0599.","journal-title":"J Neurosurg"},{"key":"2144_CR109","doi-asserted-by":"publisher","unstructured":"Chu C, Liu G, Janowski M, Bulte JWM, Li S, Pearl M, Walczak P. Real-time MRI guidance for reproducible hyperosmolar opening of the blood-brain barrier in mice. Front Neurol. 2018;9. https:\/\/doi.org\/10.3389\/fneur.2018.00921.","DOI":"10.3389\/fneur.2018.00921"},{"key":"2144_CR110","doi-asserted-by":"crossref","unstructured":"Kiviniemi V, Korhonen V, Kortelainen J, Rytky S, Kein\u00e4nen T, Tuovinen T, Isokangas M, Sonkaj\u00e4rvi E, Siniluoto T, Nikkinen J. Real-time monitoring of human blood-brain barrier disruption. PLoS ONE. 2017;12:e0174072.","DOI":"10.1371\/journal.pone.0174072"},{"key":"2144_CR111","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.ymthe.2018.08.005","volume":"26","author":"BMDC Godinho","year":"2018","unstructured":"Godinho BMDC, Henninger N, Bouley J, Alterman JF, Haraszti RA, Gilbert JW, Sapp E, Coles AH, Biscans A, Nikan M, Echeverria D, DiFiglia M, Aronin N, Khvorova A. Transvascular Delivery of Hydrophobically Modified siRNAs: gene silencing in the rat brain upon disruption of the blood-brain barrier. Mol Ther. 2018;26:2580\u201391. https:\/\/doi.org\/10.1016\/j.ymthe.2018.08.005.","journal-title":"Mol Ther"},{"key":"2144_CR112","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.2174\/092986711795496746","volume":"18","author":"M Munoz","year":"2011","unstructured":"Munoz M, Covenas R. NK-1 receptor antagonists: a new paradigm in pharmacological therapy. Curr Med Chem. 2011;18:1820\u201331.","journal-title":"Curr Med Chem"},{"key":"2144_CR113","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pneurobio.2018.01.003","volume":"165","author":"A Nokkari","year":"2018","unstructured":"Nokkari A, Abou-El-Hassan H, Mechref Y, Mondello S, Kindy MS, Jaffa AA, Kobeissy F. Implication of the kallikrein-kinin system in neurological disorders: quest for potential biomarkers and mechanisms. Prog Neurobiol. 2018;165:26\u201350.","journal-title":"Prog Neurobiol"},{"key":"2144_CR114","unstructured":"Rasmuson J. Neutrophil-induced endothelial barrier dysfunction in acute inflammation: mechanisms and therapeutic strategies. 2020."},{"key":"2144_CR115","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/sj.bjp.0705554","volume":"140","author":"B Erdlenbruch","year":"2003","unstructured":"Erdlenbruch B, Alipour M, Fricker G, Miller DS, Kugler W, Eibl H, Lakomek M. Alkylglycerol opening of the blood\u2013brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries. Br J Pharmacol. 2003;140:1201\u201310.","journal-title":"Br J Pharmacol"},{"key":"2144_CR116","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/sj.bjp.0705302","volume":"139","author":"B Erdlenbruch","year":"2003","unstructured":"Erdlenbruch B, Schinkhof C, Kugler W, Heinemann DE, Herms J, Eibl H, Lakomek M. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain. Br J Pharmacol. 2003;139:685\u201394.","journal-title":"Br J Pharmacol"},{"key":"2144_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-36340-0","volume":"9","author":"T Mainprize","year":"2019","unstructured":"Mainprize T, Lipsman N, Huang Y, Meng Y, Bethune A, Ironside S, Heyn C, Alkins R, Trudeau M, Sahgal A, Perry J, Hynynen K. Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study. Sci Rep. 2019;9:1\u20137. https:\/\/doi.org\/10.1038\/s41598-018-36340-0.","journal-title":"Sci Rep"},{"key":"2144_CR118","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jconrel.2018.12.048","volume":"295","author":"T Shapira-Furman","year":"2019","unstructured":"Shapira-Furman T, Serra R, Gorelick N, Doglioli M, Tagliaferri V, Cecia A, Peters M, Kumar A, Rottenberg Y, Langer R. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer. J Control Release. 2019;295:93\u2013101.","journal-title":"J Control Release"},{"key":"2144_CR119","doi-asserted-by":"publisher","first-page":"E10281","DOI":"10.1073\/pnas.1713328114","volume":"114","author":"T Sun","year":"2017","unstructured":"Sun T, Zhang Y, Power C, Alexander PM, Sutton JT, Aryal M, Vykhodtseva N, Miller EL, McDannold NJ. Closed-loop control of targeted ultrasound drug delivery across the blood\u2013brain\/tumor barriers in a rat glioma model. PNAS. 2017;114:E10281\u201390. https:\/\/doi.org\/10.1073\/pnas.1713328114.","journal-title":"PNAS"},{"key":"2144_CR120","doi-asserted-by":"publisher","first-page":"15288","DOI":"10.1021\/ja038345f","volume":"125","author":"S Zhang","year":"2003","unstructured":"Zhang S, Trokowski R, Sherry AD. A paramagnetic CEST agent for imaging glucose by MRI. J Am Chem Soc. 2003;125:15288\u20139. https:\/\/doi.org\/10.1021\/ja038345f.","journal-title":"J Am Chem Soc"},{"key":"2144_CR121","doi-asserted-by":"publisher","unstructured":"Vezina A, Jackson S. SCIDOT-21. Improving drug delivery to glioblastoma by targeting canonical WNT\/\u03b2-catenin signaling in the blood-brain barrier. Neuro Oncol. 2019;21:vi275-vi276. https:\/\/doi.org\/10.1093\/neuonc\/noz175.1157","DOI":"10.1093\/neuonc\/noz175.1157"},{"key":"2144_CR122","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11060-017-2404-1","volume":"132","author":"S Jackson","year":"2017","unstructured":"Jackson S, George RT, Lodge MA, Piotrowski A, Wahl RL, Gujar SK, Grossman SA. The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot study. J Neurooncol. 2017;132:513\u20139. https:\/\/doi.org\/10.1007\/s11060-017-2404-1.","journal-title":"J Neurooncol"},{"key":"2144_CR123","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2020.01.024","volume":"474","author":"O Bozinov","year":"2020","unstructured":"Bozinov O, Yang Y, Oertel MF, Neidert MC, Nakaji P. Laser interstitial thermal therapy in gliomas. Cancer Lett. 2020;474:151\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2020.01.024.","journal-title":"Cancer Lett"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02144-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-021-02144-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02144-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T16:13:49Z","timestamp":1647274429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-021-02144-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2144"],"URL":"https:\/\/doi.org\/10.1208\/s12249-021-02144-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,3]]},"assertion":[{"value":"26 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"11"}}